Endpoints and Design for Clinical Trials in <i>USH2A</i>-Related Retinal Degeneration: Results and Recommendations From the RUSH2A Natural History Study - Concepedia

Concepedia

Publication | Open Access

Endpoints and Design for Clinical Trials in <i>USH2A</i>-Related Retinal Degeneration: Results and Recommendations From the RUSH2A Natural History Study

DOI Full Paper Access

13

Citations

33

References

2024

Year

Maureen G. Maguire, David G. Birch, Jacque L. Duncan, Allison R. Ayala, Lauren N. Ayton, Janet K. Cheetham, Peiyao Cheng, Todd A. Durham, Frederick L. Ferris, Carel B. Hoyng,

Translational Vision Science & Technology

Abstract

Analyses of natural history data from the Rate of Progression in USH2A-Related Retinal Degeneration (RUSH2A) study can inform eligibility criteria and endpoints for clinical trials.

References

	Year	Citations

Page 1